News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gennadios Aristippos
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Gennadios Aristippos (Group Pres. Pharma & Consumer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,590 shares
@ $0
Sold 396 shares
@ $44.49, valued at
$17.6k
|
|
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| Gennadios Aristippos (Group Pres. Pharma & Consumer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 61 shares
@ $46.58, valued at
$2.8k
Sold 220 shares
@ $47.87, valued at
$10.5k
Granted 8,870 shares
@ $0
Granted 19,756 options to buy
@ $46.51, valued at
$918.9k
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/26/2022 |
4
| Gennadios Aristippos (Group Pres. Pharma & Consumer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 6,771 shares
@ $0
Sold 1,645 shares
@ $103.04, valued at
$169.5k
|
|
| 07/28/2022 |
4
| Gennadios Aristippos (Group Pres. Pharma & Consumer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 403 shares
@ $106.9, valued at
$43.1k
Granted 1,859 shares
@ $0
Granted 8,078 options to buy
@ $107.63, valued at
$869.4k
|
|
| 07/05/2022 |
4
| Gennadios Aristippos (Group Pres. Pharma & Consumer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 18,689 shares
@ $107.02, valued at
$2M
|
|
| 01/05/2022 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 4,017 shares
@ $0 |
|
| 08/30/2021 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 8,008 shares
@ $0
Sold 171 shares
@ $130.29, valued at
$22.3k
Sold 2,091 shares
@ $131.2, valued at
$274.3k
|
|
| 07/28/2021 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 465 shares
@ $113.05, valued at
$52.6k
Granted 885 shares
@ $0
Granted 4,579 options to buy
@ $113, valued at
$517.4k
|
|
| 01/05/2021 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 110 shares
@ $104.42, valued at
$11.5k
|
|
| 12/23/2020 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 3,936 shares
@ $102.95, valued at
$405.2k
Sold 9,726 shares
@ $102.8, valued at
$999.8k
Exercised 3,936 options to buy
@ $24.44, valued at
$96.2k
Exercised 9,726 options to buy
@ $36.02, valued at
$350.3k
|
|
| 08/31/2020 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 10,737 shares
@ $0
Paid exercise price by delivering 4,226 shares
@ $87.71, valued at
$370.7k
Granted 400 shares
@ $0
Paid exercise price by delivering 158 shares
@ $87.71, valued at
$13.9k
|
|
| 08/03/2020 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,136 shares
@ $0
Granted 6,158 options to buy
@ $88.1, valued at
$542.5k
|
|
| 07/28/2020 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 984 shares
@ $81.64, valued at
$80.3k
|
|
| 06/29/2020 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 7,039 shares
@ $73, valued at
$513.8k
Paid exercise price by delivering 6,891 shares
@ $73, valued at
$503k
Sold 8,325 shares
@ $73, valued at
$607.7k
Exercised 11,799 options to buy
@ $24.44, valued at
$288.4k
Exercised 10,456 options to buy
@ $31.96, valued at
$334.2k
|
|
| 04/13/2020 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 279 shares
@ $56.46, valued at
$15.8k
|
|
| 11/27/2019 |
4
| Gennadios Aristippos (President Softgel & Oral Tech) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 708 shares
@ $52.55, valued at
$37.2k
Paid exercise price by delivering 4,022 shares
@ $52.55, valued at
$211.4k
Paid exercise price by delivering 2,106 shares
@ $52.55, valued at
$110.7k
Paid exercise price by delivering 3,324 shares
@ $52.55, valued at
$174.7k
Paid exercise price by delivering 57,597 shares
@ $52.55, valued at
$3M
Paid exercise price by delivering 10,858 shares
@ $52.55, valued at
$570.6k
Sold 45,256 shares
@ $52.55, valued at
$2.4M
Exercised 1,176 options to buy
@ $12.14, valued at
$14.3k
Exercised 6,764 options to buy
@ $12.14, valued at
$82.1k
Exercised 3,500 options to buy
@ $12.14, valued at
$42.5k
Exercised 5,236 options to buy
@ $18.71, valued at
$98k
|
|
| 08/26/2019 |
4
| Gennadios Aristippos (President, Softgel Tech.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 12,420 shares
@ $0
Paid exercise price by delivering 3,805 shares
@ $55.24, valued at
$210.2k
|
|
| 07/30/2019 |
4
| Gennadios Aristippos (President, Softgel Tech.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 748 shares
@ $57.26, valued at
$42.8k
|
|
| 07/24/2019 |
4
| Gennadios Aristippos (President, Softgel Tech.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,639 shares
@ $0
Granted 8,830 options to buy
@ $54.94, valued at
$485.1k
|
|
| 03/25/2019 |
4
| Gennadios Aristippos (President, Softgel Tech.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 5,794 shares
@ $42.17, valued at
$244.3k
Paid exercise price by delivering 950 shares
@ $42.16, valued at
$40.1k
Sold 3,326 shares
@ $42.17, valued at
$140.3k
Sold 66 shares
@ $42.91, valued at
$2.8k
Exercised 13,528 options to buy
@ $10.71, valued at
$144.9k
|
|
| 09/05/2018 |
4
| Gennadios Aristippos (President, Softgel Tech.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 7,000 options to buy
@ $18.71, valued at
$131k
|
|
| 08/27/2018 |
4
| Gennadios Aristippos (President, Softgel Tech.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 6,757 shares
@ $0 |
|
| 07/25/2018 |
4
| Gennadios Aristippos (President, Softgel Tech.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 2,052 shares
@ $0
Granted 10,523 options to buy
@ $43.88, valued at
$461.7k
|
|
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2016 |
4
| Gennadios Aristippos (See Remarks) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 13,528 options to buy
@ $10.71, valued at
$144.9k
Granted 6,764 options to buy
@ $12.14, valued at
$82.1k
Granted 20,374 options to buy
@ $18.71, valued at
$381.2k
|
|
| 07/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|